Capital markets deal puts spotlight on Marcus & Millichap stock

Marcus & Millichap (MMI) is back on investor radars after its IPA Capital Markets division arranged $123 million in debt financing, plus preferred equity, for a 268 unit luxury multifamily property in Burlingame, California.

The financing headline lands at a time when momentum in the stock has been mixed, with a 7 day share price return of 6.59% and a 90 day share price return of 12.40%, but a 5 year total shareholder return that is down 15.91%.

If this financing deal has you looking beyond one company, it could be a good moment to widen your search and check out 20 top founder-led companies

With the stock up 6.59% in the past week and 12.40% over 90 days, yet down 15.91% over five years, the real question is whether Marcus & Millichap is undervalued or whether markets have already priced in its prospects.

Most Popular Narrative: 7.5% Overvalued

Analysts in the most followed narrative see fair value at $28, compared with a last close of $30.10. This puts the stock slightly above that estimate using an 8.55% discount rate.

The company is benefiting from renewed institutional investor activity and an improving lending environment, which is fueling larger transaction volumes and a stronger capital markets pipeline. Both factors are cited as potential drivers of future revenue and earnings growth. Ongoing investments in technology, including AI and centralized production support, are expected to enhance operational efficiency, lower costs, and increase productivity over time, supporting expansion in net margins.

Curious what kind of revenue lift and margin profile analysts need to justify that fair value, and how long they think it takes to get there? The narrative leans heavily on higher earnings power, a richer profit margin and a future valuation multiple that is very different from where the stock sits today.

Result: Fair Value of $28 (OVERVALUED)

However, the story cuts both ways. Fee pressure on commissions and potential disruption from proptech platforms pose clear challenges to the current bullish narrative.

Another Take on Valuation

The analyst narrative sees Marcus & Millichap as about 7.5% overvalued at $30.10 against a $28 fair value, based on future earnings and a 14.98x P/E in 2029. Yet on revenue, the stock trades at a P/S of 1.5x, well above peers at 0.5x and above a fair ratio of 0.8x. This points to richer pricing and less room for error if those growth and margin assumptions do not play out as expected. The key question is which signal you put more weight on.

Next Steps

With sentiment in this article pulling in both directions, it makes sense to move quickly, review the underlying numbers yourself, and pressure test the assumptions that matter most to you with 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop at just one stock, you risk missing other setups that match your style, so use the tools available and keep your opportunity set broad.

• Target resilience first by scanning 61 resilient stocks with low risk scores that may help you sleep better at night when markets turn volatile.
• Hunt for quality at a discount using 49 high quality undervalued stocks to surface companies where fundamentals and pricing look out of sync.
• Spot potential early movers through screener containing 21 high quality undiscovered gems before they sit firmly on everyone else's watchlist.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.